Aspira Women's Health Inc.
AWHL· OTC
Released Mar 27, 2025, after the close
10-K filed Mar 27, 2025, 86 days after period end · 0001641172-25-000983
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.35M | $2.13M | $2.15M | $1.85M |
| Net Income | -$1.39M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$3.09M |
| -$4.59M |
| -$8.96M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.